Skip to main content
Media RelationsInvestor RelationsHome
Logo SphingotecLogo Sphingotec

Scientific Publications

SphingoTec's biomarker discovery is based on the highest standard of evidence, with over 100 publications, over 100 clinical studies, and more than 100.000 patients enrolled. Browse our scientific publications to learn more about how our biomarkers can impact patient care. You can use filters to narrow your search results by Year, Biomarker and Indications.

2022 pro-NT Other

New Insights in the Control of Fat Homeostasis: The Role of Neurotensin

View the paper
2021 penKid pro-NT Heart Failure Other

Precursor fractions of neurotensin and enkephalin might point to molecular mechanisms of cancer risk modulation during a lifestyle‑intervention in germline BRCA1/2 gene mutation carriers

View the paper
2021 pro-NT Other

Pro-Neurotensin/Neuromedin N and risk of incident metabolic syndrome and diabetes mellitus in the REGARDS cohort

View the paper
2020 pro-NT Other

Pro-Neurotensin depends on renal function and is related to all-cause mortality in chronic kidney disease

View the paper
2020 pro-NT Other

Pro-neurotensin/neuromedin N and risk of cognitive impairment in a prospective study

View the paper
2020 pro-NT Other

Magnitude of rise in proneurotensin is related to amount of triglyceride appearance in blood after standardized oral intake of both saturated and unsaturated fat

View the paper
2019 pro-NT Other

Circulating pro-neurotensin in gestational diabetes mellitus

View the paper
2019 pro-NT Other

The association between plasma proneurotensin and glucose regulation is modified by country of birth

View the paper
2018 pro-NT Other

Similar pro-NT and pro-RLX2 levels after preeclampsia and after uncomplicated pregnancy

View the paper
2018 pro-NT Cardiovascular Disease

Usefulness of proneurotensin to predict cardiovascular and all-cause mortality in a United States population (from the reasons for geographic and racial differences in stroke study)

View the paper
2018 pro-NT Other

The anorexigenic peptide neurotensin relates to insulin sensitivity in obese patients after BPD or RYGB metabolic surgery

View the paper
2018 pro-NT Cardiovascular Disease Other

Proneurotensin predicts cardiovascular disease in an elderly population

View the paper
2018 pro-NT Other

Neurotensin is a lipid-induced gastrointestinal peptide associated with visceral adipose tissue inflammation in obesity

View the paper
2018 pro-NT Other

Association between systemic leptin and neurotensin concentration in adult individuals with and without type 2 diabetes mellitus

View the paper
2018 pro-NT Other

Increased plasma proneurotensin Levels identify NAFLD in adults with and without type 2 diabetes

View the paper
2017 pro-NT Other

No relation between biomarkers at age 47–49 and aortic diameter after 14–19 years of follow-up –a population-based study

View the paper
2016 pro-NT Other

Role of proneurotensin as marker of paediatric coeliac disease

View the paper
2016 pro-NT Other

An obligatory role for neurotensin in high-fat-diet induced obesity

View the paper
2016 pro-NT Cardiovascular Disease

Circulating Proneurotensin Concentrations and Cardiovascular Disease Events in the Community The Framingham Heart Study

View the paper
2015 pro-TA pro-ENK pro-NT Other

Basal plasma levels of copeptin are elevated in inactive inflammatory bowel disease after bowel resection

View the paper
2014 pro-NT Other

Validation of plasma proneurotensin as a novel biomarker for the prediction of incident breast cancer

View the paper
2012 pro-NT Cardiovascular Disease Other

Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality

View the paper
2006 pro-NT Other

Proneurotensin 1–117, a stable neurotensin precursor fragment identified in human circulation

View the paper